Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Neurology|September 25, 1999
Dysferlin is a surface membrane-associated protein that is absent in Miyoshi myopathyC Matsuda, M Aoki, Y K Hayashi, et al.Bioanalysis|August 14, 2013
Measurement of in vivo therapeutic mAb concentrations: comparison of conventional serum/plasma collection and analysis to dried blood spot samplingKatherine C Matsuda, Colin Hall, Cassandra Baker-Lee, et al.Clinical and Experimental Immunology|September 14, 2006
Inhibition of donor-derived T cells trafficking into target organs by FTY720 during acute graft-versus-host disease in small bowel transplantationJ Song, T Ito, C Matsuda, et al.Cancer|October 15, 1986
Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapyM Abe, M Hiraoka, M Takahashi, et al.Surgical Endoscopy|June 3, 2005
Advantages of laparoscope-assisted surgery for recurrent Crohn's diseaseF Uchikoshi, T Ito, R Nezu, et al.Human Molecular Genetics|September 5, 2001
The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscleC Matsuda, Y K Hayashi, M Ogawa, et al.Neuromuscular Disorders : NMD|May 1, 1995
DNA rearrangements in Japanese facioscapulohumeral muscular dystrophy patients: clinical correlationsK Goto, J H Lee, C Matsuda, et al.Clinical and Experimental Immunology|April 18, 2007
Therapeutic effect of a new immunosuppressive agent, everolimus, on interleukin-10 gene-deficient mice with colitisC Matsuda, T Ito, J Song, et al.Annals of Neurology|February 24, 2001
Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotypeI Illa, C Serrano-Munuera, E Gallardo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2016
A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC)E Oki, A Murata, K Yoshida, et al.Pageof 4